![]() |
|
|
Vol. 18, Issue 4, 1472-1479, April 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

*Departments of Anatomy and Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA 94143-2140; and
Institute of Molecular and Cellular Biosciences, University of Tokyo, Tokyo 113-0032, Japan
Submitted September 22, 2006;
Revised January 5, 2007;
Accepted February 1, 2007
Monitoring Editor: Asma Nusrat
| ABSTRACT |
|---|
|
|
|---|
-catenin and integrin
6 were located at the basolateral membrane. HPPL in cysts expressed cholangiocyte markers, including cytokeratin 19, integrin
4, and aquaporin-1, but not a hepatocyte marker, albumin. Furthermore, HPPL transported rhodamine 123, a substrate for multidrug resistance gene products, from the basal side to the central lumen. These data indicate that HPPL develop cholangiocyte-type epithelial polarity in 3D culture. Phosphatidylinositol 3-kinase signaling was essential for proliferation and survival of HPPL in culture, whereas laminin-1 was a crucial component of Matrigel for inducing epithelial polarization of HPPL. Because HPPL cysts display structural and functional similarities with bile ducts, the 3D culture of HPPL recapitulates in vivo cholangiocyte differentiation and is useful to study the molecular mechanism of bile duct development in vitro. | INTRODUCTION |
|---|
|
|
|---|
Bile duct development can be divided into two steps, i.e., cell fate decision and morphogenesis. Cell fate decision occurs in midgestation, as cholangiocytes split from hepatoblasts around the portal veins. The process of morphogenesis has been deduced from histochemical analysis of developing liver (Tan et al., 1995
; Lemaigre, 2003
). Cholangiocytes form a single cell layer called the ductal plate, which turns into a double cell layer. Luminal spaces are generated between the cell layers in late gestation, and then the ductal plate is reorganized into bile duct tubules. Several mutant mice have abnormalities of bile duct development, including mice lacking hepatocyte nuclear factor (HNF) 1
, HNF6, or HES1, and mice harboring a mutation in the Notch signaling pathway (Clotman et al., 2002
, 2005
; Coffinier et al., 2002
; Kodama et al., 2004
; McCright et al., 2002
). A human genetic disease also provides information about bile duct development; Alagille syndrome, which is caused by mutation of Jagged1, shows multiple phenotypes, including bile duct malformation (Li et al., 1997
). We previously used primary culture of hepatoblasts and overexpressed the intracellular domain of Notch, a constitutively active form, in hepatoblasts, which resulted in blocking hepatic differentiation and altered the expression of liver enriched transcription factors toward cholangiocyte differentiation (Tanimizu and Miyajima, 2004
). These studies have increased the number of molecules that are implicated in bile duct development. However, it has still been difficult to tell whether a molecule is involved in cell fate decision and/or in morphogenesis of bile ducts and how it regulates bile duct formation. Because primary culture of fetal liver cells has revealed the molecular mechanisms of hepatocyte differentiation (Kamiya et al., 1999
; Ito et al., 2000
; Matsui et al., 2002
), a good culture system in which liver progenitors become differentiated cholangiocytes may greatly improve our understanding of bile duct development.
In previous work, we established a cell line named HPPL, which is derived from mouse hepatoblasts (Tanimizu et al., 2004
). HPPL showed high proliferative capability and bidirectional differentiation potential as hepatoblasts. We applied a three-dimensional (3D) culture technique for HPPL, in which HPPL were embedded in a gel of extracellular matrix (ECM). HPPL showed tubule-like structures and expressed cytokeratin 19 (CK19), a conventional marker of cholangiocytes, in type I collagen. However, it turned out that these structures had no luminal space, indicating that they did not develop apicobasal polarity. Histochemical data that cholangiocytes are associated with basement membrane suggested that interaction between cholangiocytes and ECM components of the basement membrane is important for bile duct morphogenesis. Based on these data, we now added Matrigel, which has a similar composition of ECM proteins as basement membrane, to type I collagen gel to mimic the in vivo environment around developing bile ducts, and we examined the morphology of HPPL.
| MATERIALS AND METHODS |
|---|
|
|
|---|
1/activin-like receptor kinase; LY294002, an inhibitor for phosphatidylinositol 3-kinase (PI3K); and BB94, an inhibitor for matrix metalloproteinases (MMPs) with a broad spectrum, were purchased, respectively, from Promega (Madison WI), Calbiochem (La Jolla, CA), Tocris Cookson (Ellisville, MO), and British Biotech (Oxford, United Kingdom).
Cell Culture
HPPL were kept in DMEM/F-12 (Sigma-Aldrich, St. Louis, MO) containing 10% fetal bovine serum (Invitrogen, Carlsbad, CA), 1x insulin/transferrin/selenium (Invitrogen), 10 mM nicotinamide (Wako Pure Chemicals, Osaka, Japan), 0.1 µM dexamethasone (Sigma-Aldrich), 5 mM L-glutamine, and 5 ng/ml hepatocyte growth factor (HGF) and epidermal growth factor (EGF). HPPL were suspended in type I collagen gel or mixture of type I collagen and Matrigel at a density of 4 x 104 cells/ml. One hundred fifty microliters of the cell suspension was added to each 1-cm-diameter culture insert (Millipore, Billerica, MA). After incubation at 37°C for 2 h to solid the gel, 500 µl of DMEM/F-12 with or without growth factors was added on top and under the insert. All the inhibitors were dissolved in dimethyl sulfoxide and added to medium from the beginning of the 3D culture to give a final concentration of 10 µM.
Immunofluorescence Chemistry
Mouse embryonic and neonatal livers were fixed in phosphate-buffered saline containing 4% paraformaldehyde (PFA) at 4°C for
4 h. They were embedded in OCT compound and frozen and ultimately used for preparation of thin sections with a cryostat (Leica, St. Gallen, Switzerland). Samples of the 3D culture were treated with collagenase and fixed in PFA solution as reported previously (O'Brien et al., 2006
). Frozen sections and culture samples were incubated with primary antibodies listed in Table 1. Signals were visualized with AlexaFluor-conjugated secondary antibodies (Molecular Probes, Eugene, OR) used at a dilution of 1:500. F-actin bundles were detected with AlexaFluor 546- or 633-conjugated phalloidin (Molecular Probes) at a dilution of 1:250. Nuclei were counterstained with Hoechst 34580. Samples were examined on a Zeiss Pascal or 510 confocal laser scanning fluorescence microscope.
|
| RESULTS |
|---|
|
|
|---|
6 was observed on the basolateral surface of cholangiocytes and in endothelial cells of the portal vein (Figure 1K, white, and L, red). The close association between cholangiocytes and basement membrane led to a hypothesis that interactions between cholangiocytes and ECM proteins are important for bile duct morphogenesis.
|
First, we used type I collagen alone as a component of the ECM gel. HPPL grew in the gel and formed extended structures (Figure 2A). F-actin was localized all around the cell cortex (Figure 2D). Next, Matrigel, which contains ECM proteins of basement membrane, was mixed with type I collagen gel to better mimic the environment around developing bile ducts. When Matrigel was added to type I collagen up to 20% of the total volume of gel, HPPL formed extended structures and cell aggregates (Figure 2B). Importantly, F-actin localization dramatically changed compared with that in pure type I collagen gel, i.e., F-actin relocated from cellECM contacts and now surrounded small lumens at cellcell boundaries (Figure 2E, arrows). When Matrigel was increased to 40% of the total volume, HPPL formed round shape cysts instead of extended structures (Figure 2C), which had the central luminal space, surrounded by a monolayer of cells (Figure 2F). Further increase of Matrigel concentration did not affect the efficiency of cyst formation (Figure 2G). That HPPL developed cysts with the central lumen in 40% Matrigel suggested that they might have acquired apicobasal polarity.
|
-catenin as markers for the apical and the basolateral domains, respectively, to follow the time course of HPPL morphogenesis in the culture (Figure 3A). At day 1 of culture, HPPL seemed not to have developed apicobasal polarity yet, because F-actin (red) was uniformly distributed along the cell cortex. Lumens were not detected at this point. At day 3 of the culture, tiny luminal spaces surrounded by F-actin bundles (red) became evident. Actin was concentrated around the lumen. By day 7 of culture, HPPL formed round cysts with luminal spaces inside, and they showed clear basolateral localization of
-catenin (green), indicating that HPPL had acquired apicobasal polarity.
|
antibody, which actually recognizes both
and
isoforms. In addition to F-actin (Figure 3B25, red), aPKC was localized at the apical membrane (Figure 3B1, red). Besides
-catenin (Figure 3B1, green), integrin
6 (Figure 3B2, green) was observed at the basolateral membrane. E-cadherin was localized at cellcell contacts (Figure 3B3, green). Zonula occludens 1 (ZO-1) was detected at the apical tip of the lateral membrane (Figure 3B4, white), where tight junctions are formed. These data further demonstrated that HPPL developed apicobasal epithelial polarity in gels containing 40% Matrigel.
We also examined expression of the lineage markers for liver epithelial cells. CK19, a conventional marker of cholangiocytes, was detected both along plasma membranes and in the cytosol (Figure 3B4 and 5, green), whereas integrin
4 and aquaporin 1 (AQP1) were localized at the basolateral and the apical membrane, respectively (Figure 3B6, green and red, respectively). These data indicated that HPPL localized cholangiocyte markers properly. Acquisition of cholangiocyte characteristics could be further demonstrated by down-regulation of albumin, because it is expressed in liver progenitors and hepatocytes but not in mature cholangiocytes. We found that HPPL in cysts, which were positive for CK19 (Figure 3C1) and formed lumens (Figure 3C3), did not express albumin (Figure 3C2). In contrast, HPPL, which failed to form a clear luminal space (Figure 3C8) and were weakly positive for CK19 (Figure 3C6), strongly expressed albumin (Figure 3C7). These data support that HPPL in cysts differentiate along the cholangiocyte lineage.
A physiological function of cholangiocytes is secretion of small substances, including water and bicarbonate ions, to modulate bile composition. The secretion function is attributed to transmembrane channel proteins such as cystic fibrosis transmembrane regulator chloride channels and mdr P-glycoprotein 170 gene products (Fitz, 2002
). A recent article demonstrated that mdr1, which has been well characterized at the apical membrane of hepatocytes, is also functionally expressed in cholangiocytes (Gigliozzi et al., 2000
), showing functionality of mdr1 by accumulation of rhodamine 123, an mdr substrate, in the apical luminal space of bile duct units isolated from rat. To determine whether HPPL express functional mdr, HPPL cysts were incubated in the presence of rhodamine 123, and time-lapse images were taken every 2 min by checking fluorescence signal in the central lumen. We found that the fluorescence intensity gradually increased inside the luminal space, indicating that HPPL cysts transported rhodamine 123 from the basal side to the apical luminal space (Figure 4A). The transport of rhodamine 123 almost reached a plateau after 20 min of incubation (Figure 4B). Furthermore, rhodamine 123 was trapped inside cells but not transported into the central lumen in the presence of 10 µM verapamil, an mdr inhibitor, at 40 min of incubation (Figure 4C, right), indicating that the transport of rhodamine 123 depends on functional mdr in the apical domain. Thus, HPPL in cysts acquired not only structural but also functional characteristics of differentiated cholangiocytes.
|
|
EGF and HGF activate many intracellular signaling pathways, including MEK/ERK and PI3K/Akt pathways. To identify intracellular signals important for cyst formation, we added an MEK inhibitor, U0126, or a PI3K inhibitor, LY294002, to the culture. We counted the number of cysts at day 7 of the culture, and we found that U0126, which reduced phosphorylation of ERK (Supplemental Figure 1B), did not significantly affect cyst formation of HPPL, whereas LY294002 dramatically reduced the number of cysts (Figure 5B). Most of multicellular structures were small aggregates in the presence of LY294002 (Figure 5C). We also added inhibitors against p38 and c-Jun NH2-terminal kinase (JNK). SB202190, a p38 inhibitor, did not affect cyst formation, whereas SP600125, a JNK inhibitor, blocked cyst formation (Supplemental Figure 2). At day 2 of the culture, LY294002 significantly reduced Ki67+ cells (Figure 6A) and slightly increased cleaved caspase 3+ cells (Figure 6B), indicating that EGF and HGF use the PI3K/Akt pathway to promote proliferation and survival of HPPL during cyst formation.
|
, as well as ECM proteins. Because EGF and insulin were included in the medium, TGF
is a soluble factor that is supplied by Matrigel and might affect HPPL morphogenesis. To check this possibility, we used SB431542, an inhibitor of the TGF
RI/activin receptor-like kinase, to block the TGF
signaling pathway, and we found that the number of cysts decreased with the presence of SB431542 (Figure 5B). Although TGF
alone unlikely induces cyst morphogenesis of HPPL as Matrigel alone did not induce cyst formation, it may facilitate the function of EGF and HGF. Because cells are surrounded by ECM proteins in 3D culture, MMPs may be important for morphogenesis of HPPL. Indeed, BB94, an MMP inhibitor with broad specificity, dramatically reduced the number of cysts (Figure 5B). Most multicellular structures were small aggregates in the presence of BB94 (Figure 5C). At day 2 of the culture, BB94 significantly reduced Ki67+ cells (Figure 6A), suggesting that degradation of ECM may give HPPL some space, which allows them to proliferate in gel and undergo cyst morphogenesis. The inhibition of ECM degradation also affected cell survival, because cleaved caspase 3+ cells increased (Figure 6B), which may be another reason for that the number of cysts were reduced in the presence of BB94.
Laminin-1 Is Important for Cyst Formation
Matrigel contains basement membrane components, including laminin-1, type IV collagen, and entactin. Because laminin has been implicated in the formation of epithelial polarity (O'Brien et al., 2001
; Yu et al., 2005
), we hypothesized that it could replace Matrigel to induce cyst formation of HPPL. To test this, we mixed high concentration laminin-1/entactin complex with type I collagen, and we examined morphology of HPPL. When laminin-1 was added to type I collagen up to 40% of the total volume, HPPL developed apicobasal polarity and formed cysts with the central lumen (Figure 7A). In contrast, when type IV collagen, another major ECM protein in Matrigel, was added to type I collagen, HPPL still formed extended structures, although tiny lumens were generated (Figure 7B). These data demonstrated that laminin-1 is a major ECM protein contained in Matrigel that induces cyst formation of HPPL.
|
| DISCUSSION |
|---|
|
|
|---|
EGF and HGF are important factors for HPPL cyst formation. EGF family ligands have been implicated in proliferation of cholangiocytes; TGF
and EGF receptor were detected in cholangiocytes of intrahepatic bile ducts (Terada et al., 1994
). Cholangiocytes isolated from polycystic kidney (PCK) rats, which suffer from cystic liver, overexpressed MEK5 and showed hyperresponsiveness to EGF, leading to abnormal proliferation (Sato et al., 2005
). Here, we demonstrated that PI3K activated by EGF in combination with HGF promoted proliferation of HPPL during cyst morphogenesis, suggesting that the PI3K pathway in addition to MEK5/ERK5 could be important for cholangiocyte proliferation in vivo. Thus, future studies on the roles of PI3K in HPPL morphogenesis may reveal the molecular mechanisms governing cholangiocyte proliferation both in bile duct development and disease.
Studies of PCK rats indicate that overproliferation of cholangiocytes results in expansion of bile ducts, leading to cyst formation in PCK rats. This suggests that size of the apical lumen of bile ducts may be determined by proliferative capability of cholangiocytes. However, more proliferation did not change the size of the central lumen of HPPL cysts in 3D culture (Supplemental Figure 3). The combination of EGF and HGF increased the number of Ki67+ cells compared with either EGF or HGF alone, although the size of the central lumen was not increased. In contrast, cysts with a large central lumen were not efficiently formed in cultures without EGF and HGF, in which HPPL did not proliferate. These results suggest that proliferation is necessary for forming cysts with a large central lumen but that it is not sufficient for increasing the size of the lumen.
OSM inhibited cyst formation induced by EGF and HGF without affecting expression of CK19 and albumin. OSM is known to regulate expression of numerous genes, including tissue inhibitors of metalloproteinase (TIMPs) (Bugno et al., 1995
; Nakamura et al., 2004
; Weiss et al., 2005
). Moreover, mRNA levels of TIMP1 and -2 at day 7 increased, respectively, by 13- and 4-fold (our unpublished data). Considering that BB94, an inhibitor for MMPs, dramatically reduced the number of cysts, the reduction of MMP activity by the increase of TIMPs in the presence of OSM might inhibit cyst formation.
Matrigel, which has a similar ECM composition with basement membrane, was necessary for HPPL to develop cholangiocyte-type epithelial polarity in the culture. Because laminin-1 induced cyst formation in the absence of Matrigel, it is one of the major components of Matrigel crucial for polarization of HPPL. In contrast, type IV collagen did not induced cyst formation. However, the concentration of type IV collagen was lower than laminin-1 in these experiments, because a higher concentration type IV collagen was not available. So, we cannot rule out that a higher concentration of type IV collagen might help cyst formation. We considered the possibility that HPPL do not produce ECM proteins and therefore that laminin-1, at least, must be supplied in the culture. Unexpectedly, we found that HPPL produced ECM proteins, including laminin
5,
1,
2,
1,
2 subunits, as detected by reverse transcription-polymerase chain reaction (our unpublished data). However, they were unlikely to be involved in formation of apicobasal polarity, because most of cysts were not associated with a laminin
5 layer at day 7 of the culture (our unpublished data). Thus, laminin-1 supplied in the culture probably mimics the role of in vivo basement membrane and induces apicobasal polarity of HPPL. Later, ECM proteins produced by HPPL might assemble to the basement membrane and contribute to the maintenance of the polarity. In contrast, because BB94 significantly inhibited cyst formation, the degradation of ECM proteins by MMPs is an important step for cyst formation of HPPL. MMP activities are probably important also for in vivo bile duct formation, because several MMPs were detected around bile ducts in developing liver (Terada et al., 1995
). Thus, both the integrity of basement membrane and its degradation are important for cholangiocyte morphogenesis both in vitro and in vivo. The 3D culture system is useful to examine the relationship between production/assembly and degradation of ECM proteins during bile duct morphogenesis.
Our data demonstrate that the cyst formation by HPPL recapitulates several aspects of in vivo cholangiocyte differentiation. It has been difficult to approach detailed mechanisms of bile duct development only using mutant mice and organ culture. Thus, it is worth examining roles of molecules such as TGF
, HNF1
, and Notch in cyst formation to know their contributions to cholangiocyte differentiation and morphogenesis. Besides these known molecules, we can now explore novel molecular pathways controlling cholangiocyte differentiation by disrupting genes in the 3D culture and characterizing the effects on morphology of HPPL. We expect that this novel culture system will help us to understand the molecular mechanism governing bile duct development and its disruption in disease.
| ACKNOWLEDGMENTS |
|---|
| Footnotes |
|---|
The online version of this article contains supplemental material at MBC Online (http://www.molbiolcell.org). ![]()
Address correspondence to: Keith E. Mostov (keith.mostov{at}ucsf.edu)
| REFERENCES |
|---|
|
|
|---|
Bugno, M., Graeve, L., Gatsios, P., Koj, A., Heinrich, P. C., Travis, J., Kordula, T. (1995). Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter. Nucleic Acids Res 23, 50415047.
Clotman, F., Jacquemin, P., Plumb-Rudewiez, N., Pierreux, C. E., Van der Smissen, P., Dietz, H. C., Courtoy, P. J., Rousseau, G. G., Lemaigre, F. P. (2005). Control of liver cell fate decision by a gradient of TGFbeta signaling modulated by onecut transcription factors. Genes Dev 19, 18491854.
Clotman, F., Lannoy, V. J., Reber, M., Cereghini, S., Cassiman, D., Jacquemin, P., Roskams, T., Rousseau, G. G., Lemaigre, F. P. (2002). The onecut transcription factor HNF6 is required for normal development of the biliary tract. Development 129, 18191828.[Medline]
Coffinier, C., Gresh, L., Fiette, L., Tronche, F., Schutz, G., Babinet, C., Pontoglio, M., Yaniv, M., Barra, J. (2002). Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1
. Development 129, 18291838.[Medline]
Fitz, J. G. (2002). Regulation of cholangiocyte secretion. Semin. Liver Dis 22, 241249.[CrossRef][Medline]
Gigliozzi, A., Fraioli, F., Sundaram, P., Lee, J., Mennone, A., Alvaro, D., Boyer, J. L. (2000). Molecular identification and functional characterization of Mdr1a in rat cholangiocytes. Gastroenterology 119, 11131122.[CrossRef][Medline]
Ito, Y., Matsui, T., Kamiya, A., Kinoshita, T., Miyajima, A. (2000). Retroviral gene transfer of signaling molecules into murine fetal hepatocytes defines distinct roles for the STAT3 and ras pathways during hepatic development. Hepatology 32, 13701376.[CrossRef][Medline]
Kamiya, A., et al. (1999). Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer. EMBO J 18, 21272136.[CrossRef][Medline]
Kikkawa, Y., Mochizuki, Y., Miner, J. H., Mitaka, T. (2005). Transient expression of laminin alpha1 chain in regenerating murine liver: restricted localization of laminin chains and nidogen-1. Exp. Cell Res 305, 99109.[CrossRef][Medline]
Kinoshita, T. and Miyajima, A. (2002). Cytokine regulation of liver development. Biochim. Biophys. Acta 1592, 303312.[Medline]
Kodama, Y., Hijikata, M., Kageyama, R., Shimotohno, K., Chiba, T. (2004). The role of notch signaling in the development of intrahepatic bile ducts. Gastroenterology 127, 17751786.[CrossRef][Medline]
Lemaigre, F. P. (2003). Development of the biliary tract. Mech. Dev 120, 8187.[CrossRef][Medline]
Li, L., et al. (1997). Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat. Genet 16, 243251.[CrossRef][Medline]
Matsui, T., Kinoshita, T., Morikawa, Y., Tohya, K., Katsuki, M., Ito, Y., Kamiya, A., Miyajima, A. (2002). K-Ras mediates cytokine-induced formation of E-cadherin-based adherens junctions during liver development. EMBO J 21, 10211030.[CrossRef][Medline]
McCright, B., Lozier, J., Gridley, T. (2002). A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 129, 10751082.[Medline]
Mostov, K., et al. (2005). Formation of multicellular epithelial structures. Novartis Found Symp 269, 193200 discussion 200205, 223230.[Medline]
Nakamura, K., Nonaka, H., Saito, H., Tanaka, M., Miyajima, A. (2004). Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice. Hepatology 39, 635644.[CrossRef][Medline]
O'Brien, L. E., Jou, T. S., Pollack, A. L., Zhang, Q., Hansen, S. H., Yurchenco, P., Mostov, K. E. (2001). Rac1 orientates epithelial apical polarity through effects on basolateral laminin assembly. Nat. Cell Biol 3, 831838.[CrossRef][Medline]
O'Brien, L. E., Yu, W., Tang, K., Jou, T. S., Zegers, M. M., Mostov, K. E. (2006). Morphological and biochemical analysis of Rac1 in three-dimensional epithelial cell cultures. Methods Enzymol 406, 676691.[Medline]
Sato, Y., Harada, K., Kizawa, K., Sanzen, T., Furubo, S., Yasoshima, M., Ozaki, S., Ishibashi, M., Nakanuma, Y. (2005). Activation of the MEK5/ERK5 cascade is responsible for biliary dysgenesis in a rat model of Caroli's disease. Am. J. Pathol 166, 4960.
Spagnoli, F. M., Amicone, L., Tripodi, M., Weiss, M. C. (1998). Identification of a bipotential precursor cell in hepatic cell lines derived from transgenic mice expressing cyto-Met in the liver. J. Cell Biol 143, 11011112.
Strick-Marchand, H. and Weiss, M. C. (2002). Inducible differentiation and morphogenesis of bipotential liver cell lines from wild-type mouse embryos. Hepatology 36, 794804.[Medline]
Tan, C. E., Chan, V. S., Yong, R. Y., Vijayan, V., Tan, W. L., Fook Chong, S. M., Ho, J. M., Cheng, H. H. (1995). Distortion in TGF beta 1 peptide immunolocalization in biliary atresia: comparison with the normal pattern in the developing human intrahepatic bile duct system. Pathol. Int 45, 815824.[Medline]
Tanimizu, N. and Miyajima, A. (2004). Notch signaling controls hepatoblast differentiation by altering the expression of liver-enriched transcription factors. J. Cell Sci 117, 31653174.
Tanimizu, N., Saito, H., Mostov, K., Miyajima, A. (2004). Long-term culture of hepatic progenitors derived from mouse Dlk+ hepatoblasts. J. Cell Sci 117, 64256434.
Terada, T., Ohta, T., Nakanuma, Y. (1994). Expression of transforming growth factor-alpha and its receptor during human liver development and maturation. Virchows Arch 424, 669675.[CrossRef][Medline]
Terada, T., Okada, Y., Nakanuma, Y. (1995). Expression of matrix proteinases during human intrahepatic bile duct development. A possible role in biliary cell migration. Am. J. Pathol 147, 12071213.[Abstract]
Weiss, T. W., Kvakan, H., Kaun, C., Zorn, G., Speidl, W. S., Pfaffenberger, S., Maurer, G., Huber, K., Wojta, J. (2005). The gp130 ligand oncostatin M regulates tissue inhibitor of metalloproteinases-1 through ERK1/2 and p38 in human adult cardiac myocytes and in human adult cardiac fibroblasts: a possible role for the gp130/gp130 ligand system in the modulation of extracellular matrix degradation in the human heart. J. Mol. Cell Cardiol 39, 545551.[CrossRef][Medline]
Yu, W., O'Brien, L. E., Wang, F., Bourne, H., Mostov, K. E., Zegers, M. M. (2003). Hepatocyte growth factor switches orientation of polarity and mode of movement during morphogenesis of multicellular epithelial structures. Mol. Biol. Cell 14, 748763.
Yu, W., Datta, A., Leroy, P., O'Brien, L. E., Mak, G., Jou, T. S., Matlin, K. S., Mostov, K. E., Zegers, M. M. (2005). Beta1-integrin orients epithelial polarity via Rac1 and laminin. Mol. Biol. Cell 16, 433445.
Zegers, M. M., O'Brien, L. E., Yu, W., Datta, A., Mostov, K. E. (2003). Epithelial polarity and tubulogenesis in vitro. Trends Cell Biol 13, 169176.[CrossRef][Medline]
This article has been cited by other articles:
![]() |
N. Tanimizu, A. Miyajima, and K. E. Mostov Liver Progenitor Cells Fold Up a Cell Monolayer into a Double-layered Structure during Tubular Morphogenesis Mol. Biol. Cell, May 1, 2009; 20(9): 2486 - 2494. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hashimoto, R. Sudo, K. Fukasawa, M. Ikeda, T. Mitaka, and K. Tanishita Ductular Network Formation by Rat Biliary Epithelial Cells in the Dynamical Culture with Collagen Gel and Dimethylsulfoxide Stimulation Am. J. Pathol., August 1, 2008; 173(2): 494 - 506. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||